F016 Red Flags and Emergencies in Dermatology
DESCRIPTION
It is often believed that dermatology does not involve life-threatening situations, with many observers considering skin disorders as being only “skin deep” and of no more than aesthetic/cosmetic importance. The truth is that the dermatology unit is no stranger to life-threatening skin diseases or serious and lethal systemic diseases with cutaneous manifestations. Moreover, dermatologists are not spared the possibility of needing to deal with severely sick patients. Indeed, dermatologists are frequently the first physicians to examine a patient, thus becoming responsible for making the initial diagnosis of grave conditions that require urgent attention. The present session will provide descriptions of a selection of acute, severe, life-threatening skin diseases, with the aim of guiding dermatologists in rapid and accurate diagnostic decision-making, and be better able to carry out the appropriate urgent interventions, for these conditions.
LEARNING OBJECTIVES
Diagnose acute life-threatening skin diseases or serious and lethal systemic diseases with cutaneous manifestations.
Identify critical dermatological situations, recognize red flags that signal real emergencies, and differentiate them from everyday skin ailments that do not pose any immediate danger or emergency.
Describe the pathological aspects of life-threatening skin diseases, better able to carry out the appropriate urgent interventions, and be well-informed about the most up-to-date treatments available for these conditions.
SCHEDULE
1:00 PM
Introduction
Ronni Wolf, MD, IFAAD
1:15 PM
Eschars: Markers of Severe Illness
Theodore Rosen, MD, FAAD
1:40 PM
Dermatological Urgent Care: When Banalities Surprise You
Warren R. Heymann, MD, FAAD
2:05 PM
Erythroderma: Diagnosing and Treating the "Red Man"
Lawrence C Parish, MD, FAAD
2:25 PM
Catastrophes in Cosmetic Procedures
Anthony V. Benedetto, DO, FAAD
2:45 PM
Questions & Answers
DIRECTOR
Ronni Wolf, MD, IFAAD
SPEAKERS
Anthony V. Benedetto, DO, FAAD
Warren R. Heymann, MD, FAAD
Lawrence C Parish, MD, FAAD
Theodore Rosen, MD, FAAD
DISCLOSURES
Anthony V. Benedetto, DO, FAAD
AbbVie – Investigator(Fees), Stockholder Private Company(Fees); BioDelivery Systems, Inc. – Stockholder(Stock Options); Bristol-Myers Squibb – Stockholder(Stock); Castle Biosciences, Inc – Advisory Board(Honoraria); GSK PLC – Stockholder Private Company(Stock); Ipsen – Speaker(Honoraria); IQVIA – Investigator(Fees); Merz Pharmaceuticals, LLC – Stockholder Public Company(No Compensation Received); Organogenesis, Inc. – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Stock); Stratapharma – Consultant(Honoraria), Investigator(Honoraria), Speaker(Honoraria);
Warren R. Heymann, MD, FAAD
No financial relationships exist with ineligible companies.
Lawrence C Parish, MD, FAAD
No financial relationships exist with ineligible companies.
Theodore Rosen, MD, FAAD
No financial relationships exist with ineligible companies.
Ronni Wolf, MD, IFAAD
No financial relationships exist with ineligible companies.